# Treatment of Gastroesophageal Reflux Disease in Infants

> **NCT06255886** · PHASE4 · RECRUITING · sponsor: **Odense University Hospital** · enrollment: 96 (estimated)

## Conditions studied

- Gastroesophageal Reflux
- Infant, Newborn, Diseases

## Interventions

- **DRUG:** Protein pump inhibitor.
- **BEHAVIORAL:** Mother or infant diet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06255886
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-27
- **Primary completion:** 2026-12-26
- **Final completion:** 2026-12-26
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06255886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06255886, "Treatment of Gastroesophageal Reflux Disease in Infants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06255886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*